Clinical Trial Update: A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of KH607 tablets for adults with Major Depressive Disorder, with the study currently not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• KH607

Snippet

Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: NOT_YET_RECRUITING